Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Xerostomia 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Radiation Injuries 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Neurotoxicity Syndromes 1Multiple Myeloma 1Lung Neoplasms 1Hydatidiform Mole 1Hepatoblastoma 1Head and Neck Neoplasms 1Gestational Trophoblastic Disease 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Methotrexate 2Dactinomycin 2Vincristine 1Vacuum Curettage 1Paclitaxel 1Moxifloxacin 1Etoposide 1Drug Therapy 1Cyclophosphamide 1Cisplatin 1Carboplatin 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Gestational Trophoblastic Disease × Amifostine × Clear all
NCT00058071 2013-07-09

Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer

GOG Foundation

Phase 3 Completed
100 enrolled
Gynecologic

Hydatidiform Mole, Peripheral Nervous System Diseases, Neurotoxicity Syndromes, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡